Research.Patient.info
Chronic Lymphocytic Leukemia research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE1, PHASE2
ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia
This study is testing a new medicine called acalabrutinib for people with certain types of blood cancer, like chronic lymphocytic leukaemia. It's looking to see if the medicine is safe and helps treat these conditions, especially when other treatments haven't worked.
United States · Italy · United Kingdom - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A Phase 1 Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib or Venetoclax in Participants with Relapsed/Refractory Hematologic Malignancies
This study is testing a new drug, PRT2527, sometimes combined with other medicines. It's for adults with certain blood cancers like leukaemia and lymphoma that haven't responded to previous treatments. It aims to see if the new drug is safe and how it works.
Germany · Poland · Italy